|
TAS::75 0849::TAS ADMINISTRATIVE MODIFICATION
|
261200800001E
|
$313,286,406
|
$4,314
|
DMITROVSKY, ETHAN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
High-Dimensional Immune Monitoring of NCI-Supported Immunotherapy Trials
|
1U24CA224319-01
|
$13,559,983
|
|
GNJATIC, SACHA
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Immune Monitoring and Analysis of Cancer at Stanford (IMACS)
|
1U24CA224309-01
|
$12,560,000
|
|
MAECKER, HOLDEN
|
STANFORD UNIVERSITY
|
|
Translational Cancer Immune Monitoring and Analysis Center (TCIMAC)
|
1U24CA224285-01
|
$11,005,230
|
|
WISTUBA, IGNACIO
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Immune Monitoring and Analysis Center
|
1U24CA224331-01
|
$10,708,495
|
|
WU, CATHERINE
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
2P30CA082103-19
|
$7,954,381
|
$79,544
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18S9
|
$6,765,398
|
$67,654
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S3
|
$6,166,044
|
|
FEARON, ERIC
|
UNIVERSITY OF MICHIGAN
|
|
Cancer Immunologic Data Commons
|
1U24CA224316-01
|
$5,785,000
|
|
LIU, XIAOLE
|
DANA-FARBER CANCER INST
|
|
Cancer Immunotherapy Trials Network Central Operations and Statistical Center
|
2UM1CA154967-07
|
$4,695,150
|
|
CHEEVER, MARTIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
5P30CA091842-17
|
$4,207,812
|
$84,156
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Pediatric Oncology Branch Clinical Care and Education
|
ZIE BC 011516
|
$3,462,501
|
$692,500
|
Glod, John
|
CCR (NCI)
|
|
Rational approaches to melanoma therapy
|
1U54CA224070-01
|
$2,885,586
|
|
HERLYN, MEENHARD
|
WISTAR INSTITUTE
|
|
Comprehensive Cancer Center Program at Fox Chase
|
5P30CA006927-53
|
$2,758,277
|
$275,828
|
FISHER, RICHARD
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
The MSKCC-UW/Fred Hutch Prostate Cancer Drug Resistance and Sensitivity Center
|
1U54CA224079-01
|
$2,585,894
|
|
SAWYERS, CHARLES
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
University of Texas PDX Development and Trial Center
|
1U54CA224065-01
|
$2,561,686
|
|
ROTH, JACK
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
An integrated translational approach to overcome drug resistance
|
1U54CA224068-01
|
$2,500,407
|
|
CORCORAN, RYAN
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
PDX Trial Center for Breast Cancer Therapy
|
1U54CA224076-01
|
$2,482,191
|
|
WELM, ALANA
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
5P30CA142543-09
|
$2,480,000
|
$49,600
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Overcoming Drug Resistance in Multiple Myeloma
|
1U54CA224018-01
|
$2,468,281
|
|
STEWART, ALEXANDER
|
MAYO CLINIC ARIZONA
|
|
Washington University PDX Development and Trial Center
|
1U54CA224083-01
|
$2,424,750
|
|
GOVINDAN, RAMASWAMY
|
WASHINGTON UNIVERSITY
|
|
Bay Area Team Against Resistance
|
1U54CA224081-01
|
$2,401,042
|
|
BIVONA, TREVER
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Tumor Intrinsic and Microenvironmental Mechanisms Driving Drug Combination Efficacy and Resistance in AML
|
1U54CA224019-01
|
$2,309,994
|
|
TYNER, JEFFREY
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA042014-29
|
$2,284,970
|
$22,850
|
ULRICH, CORNELIA
|
UNIVERSITY OF UTAH
|
|
Cold Spring Harbor Laboratory Cancer Research Center
|
3P01CA013106-45S1
|
$2,165,000
|
|
STILLMAN, BRUCE
|
COLD SPRING HARBOR LABORATORY
|
|
University of Hawaii Cancer Center CCSG
|
3P30CA071789-17S3
|
$2,156,000
|
|
HOLCOMBE, RANDALL
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Developmental and HyperActive Ras Tumor SPORE
|
5U54CA196519-04
|
$2,102,055
|
$1,765,726
|
CLAPP, DAVID
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Cancer Immunotherapy Trials Network Central Operations and Statistical Center
|
3U01CA154967-06S2
|
$2,100,000
|
|
CHEEVER, MARTIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-04S1
|
$2,088,480
|
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Data Coordination Center for PDX Net
|
1U24CA224067-01
|
$1,974,874
|
|
CHUANG, JEFFREY
|
JACKSON LABORATORY
|
|
Defining neoantigen immunodominance for antigen selection and biomarker discovery in human pancreatic cancer immunotherapy
|
1U01CA224175-01
|
$1,850,296
|
|
BALACHANDRAN, VINOD
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Disrupting the immune and drug-privileged microenvironment in pancreas cancer
|
1U01CA224193-01
|
$1,846,829
|
|
HINGORANI, SUNIL
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Systematic interrogation of the pancreatic cancer microenvironment in patient-derived specimens
|
1U01CA224146-01
|
$1,845,039
|
|
HAHN, WILLIAM
|
DANA-FARBER CANCER INST
|
|
U2C Kids First Admin Supplement - cloud-based data storage and compute
|
U2CHL138346-01S2
|
$1,800,000
|
|
Resnick, Adam
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Reprogramming PDAC tumor microenvironment to improve immunotherapy
|
1U01CA224348-01
|
$1,761,342
|
|
JAIN, RAKESH
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Enhancing the efficacy of immunotherapy in DLBCL using rational combination approaches
|
1U01CA224153-01
|
$1,745,768
|
|
LONDON, CHERYL
|
TUFTS UNIVERSITY BOSTON
|
|
Area A: In-Depth Proteome Mapping of the Tumor Microenvironment with Single-Cell Resolution
|
1R33CA225248-01
|
$1,744,991
|
|
KELLY, RYAN
|
BATTELLE PACIFIC NORTHWEST LABORATORIES
|
|
Area A: High Precision Single Cell Genomes: Linear Amplification and Digital Haplotypes
|
1R33CA225344-01
|
$1,708,875
|
|
XIE, XIAOLIANG SUNNEY
|
HARVARD UNIVERSITY
|
|
Coordinating Center for Canine Immunotherapy Trials and Correlative Studies
|
1U24CA224122-01
|
$1,685,614
|
|
MASON, NICOLA
|
UNIVERSITY OF PENNSYLVANIA
|
|
Pancreatic Ductal Adenocarcinoma Translational Resource Center (PATReC)
|
1U24CA224020-01
|
$1,679,941
|
|
WISTUBA, IGNACIO
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Optimizing Novel Immunotherapy Combinations Targeting the Tumor Microenvironment in Canine Spontaneous Osteosarcoma
|
1U01CA224182-01
|
$1,672,078
|
|
DOW, STEVEN
|
COLORADO STATE UNIVERSITY
|
|
2/2 Ponce School of Medicine-Moffitt Cancer Center Partnership
|
2U54CA163068-06
|
$1,656,304
|
|
MUNOZ-ANTONIA, TERESITA
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Enhancing natural killer immunotherapy with first-in-dog trials of inhaled recombinant IL-15 and super-agonist IL-15 in naturally occurring canine cancers
|
1U01CA224166-01
|
$1,639,796
|
|
CANTER, ROBERT
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Novel combined immunotherapeutic strategies for glioma: using pet dogs as a large animal spontaneous model
|
1U01CA224160-01
|
$1,632,775
|
|
Pluhar, Grace
|
UNIVERSITY OF MINNESOTA
|
|
Canine Immuno Neurotherapeutics
|
1U01CA224151-01
|
$1,596,668
|
|
Chambers, M
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Molecular Beacon Based Extracellular mRNA and Protein Detection for Early Cancer Diagnosis
|
1R33CA225380-01
|
$1,588,359
|
|
LEE, LY
|
OHIO STATE UNIVERSITY
|
|
Area B: Minimally Intrusive Colorectal Cancer Risk Stratification with Nanocytology: Targeting Underscreened Populations
|
1R33CA225323-01
|
$1,586,214
|
|
ROY, HEMANT
|
BOSTON MEDICAL CENTER
|
|
Area B: Precise DCE-MRI Assessment of Brain Tumors
|
1R33CA225400-01
|
$1,561,994
|
|
NAYAK, KRISHNA
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Area A: Development of genetically tractable, driver gene-syngeneic brain tumor models for pre-clinical adoptive TCR-T therapy
|
1R33CA225328-01
|
$1,540,837
|
|
LI, QIJING
|
DUKE UNIVERSITY
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,537,925
|
$15,379
|
Barr, Frederic
|
CCR (NCI)
|
Total relevant funding to Neurofibromatosis for this search: $9,761,176
|